Catalyst Pharmaceuticals, Inc.
NEWS
In the next two weeks, the FDA is scheduled to decide on four drug applications and hold two highly anticipated advisory committee meetings.
There were a lot of clinical trial announcements this week, driven by the European Society for Medical Oncology annual conference. Here’s a look.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Resubmission of NDA for Firdapse on schedule for end of the first quarter.
JOBS
IN THE PRESS